Related Experiment Video
Updated: Aug 11, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
Acute cholesterol depletion inhibits clathrin-coated pit budding
A Subtil1, I Gaidarov, K Kobylarz
1Department of Biochemistry, Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021, USA.
Summary
Cell membrane cholesterol is crucial for clathrin-coated pit endocytosis. Cholesterol depletion prevents coated pits from detaching, inhibiting the internalization of important molecules like transferrin receptor.
Area of Science:
- Cell biology
- Membrane trafficking
- Endocytosis
Background:
- Clathrin-coated pit endocytosis is a key cellular process for internalizing macromolecules.
- Membrane lipid composition and organization are thought to regulate membrane trafficking.
Purpose of the Study:
- To investigate the role of membrane cholesterol in clathrin-coated pit endocytosis.
- To determine how cholesterol affects the internalization of transferrin receptor.
Main Methods:
- Acute cholesterol depletion using beta-methyl-cyclodextrin.
- Live-cell imaging with a green fluorescent protein-clathrin conjugate.
- Ultrastructural analysis of coated pits.
Main Results:
- Cholesterol depletion reduced transferrin receptor internalization by over 85%.
- Coated pits failed to detach from the plasma membrane after cholesterol depletion.
- Ultrastructural studies showed an accumulation of flat-coated membranes and fewer deep-coated pits.
Conclusions:
- Membrane cholesterol is critical for clathrin-coated pit internalization.
- Cholesterol is required for the detachment of coated pits from the plasma membrane.
- Clathrin cannot induce membrane curvature in cholesterol-depleted membranes.
Related Concept Videos
Receptor-mediated Endocytosis
Overview
Receptor-mediated Endocytosis
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
COP Coated Vesicles
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of different...
Pinching-off of Coated Vesicles
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
Clathrin Coated Vesicles
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...

